AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 191 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,000 | -28.6% | 140 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 140 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -28.6% | 140 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | +40.0% | 140 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | -28.6% | 140 | 0.0% | 0.00% | – |
| Q2 2019 | $7,000 | -22.2% | 140 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $9,000 | +50.0% | 140 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -45.5% | 140 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $11,000 | -8.3% | 140 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $12,000 | +9.1% | 140 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $11,000 | +37.5% | 140 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $8,000 | -11.1% | 140 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $9,000 | +28.6% | 140 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $7,000 | – | 140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $80,873,000 | 75.24% |
| Casdin Capital, LLC | 187,500 | $7,855,000 | 7.82% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 40,000 | $1,676,000 | 4.87% |
| BB BIOTECH AG | 2,363,321 | $99,011,000 | 3.91% |
| AlpInvest Partners B.V. | 30,000 | $1,257,000 | 2.49% |
| Opaleye Management Inc. | 85,000 | $3,561,000 | 2.38% |
| Opus Point Partners Management, LLC | 43,295 | $1,814,000 | 1.75% |
| Clarius Group, LLC | 47,666 | $1,997,000 | 1.06% |
| CAPITAL INTERNATIONAL LTD /CA/ | 260,600 | $10,918,000 | 0.79% |
| Eventide Asset Management | 300,800 | $12,602,000 | 0.77% |